News
“What we are presenting today is the result of an evolution that started a few years ago.”
2021 is a special year for Debiotech and synonymous of evolution. With more than 30 years of history, the company has recently decided to share its...
Double win for NextKidney, which receives two prestigious Swiss awards in one week.
Within a week, NextKidney and its Neokidney portable home hemodialysis system received the PERL Award as well as the Venture Award. A true recognition for…
Neokidney and Debiotech join forces in NextKidney SA and appoint Jérôme Augustin CEO of the new company
Debiotech SA and Neokidney BV announced today that they are joining forces to enable NextKidney SA to finalize the development and the commercialization of…
Debiotech working on COVID19 microneedle vaccine delivery, to enhance efficiency and reduce dose.
Debiotech will be collaborating with vaccine companies, foundations and public organizations, using its unique DebioJect™ Microneedle, to improve the effectiveness…
Low-Cost Disposable Wearable Injector Platform for Large Volumes of Viscous Drugs
In this article, Eric Chappel, PhD, R&D Project Manager, Dimitry Dumont-Fillon, R&D Engineer, and Laurent-Dominique Piveteau, PhD, Chief Executive Officer, all of…
Poseidon™ and Nanopump™ presented at Pharmapack 2019 in Paris
Come and discover Poseidon™ and Nanopump™ , the two bolus injectors developed by Debiotech. They will be presented on February 6 and 7 at Pharmapack in Paris…
3D model of the portable artificial kidney presented during the symposium organized to celebrate the 50th anniversary of the Dutch Kidney Foundation
Debiotech and the Dutch Kidney Foundation presented today for the first time to the public the 3D model of the portable artificial kidney during the symposium…
Successful completion of the MyTreat project conducted in collaboration with ARTORG – University of Bern
The ARTORG Center for Biomedical Engineering Research of the University of Bern, Debiotech SA, and the Division of Endocrinology, Diabetes and Clinical Nutrition…
Publication in the British Journal of Dermatology of a study using the DebioJect™ microneedles for injecting cells into the skin
Debiotech is proud to announce the publication in the British Journal of Dermatology of the results of a study conducted in collaboration with the School of Pharmacy…
